Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing?

被引:47
作者
Epstein, Andrew J. [1 ,2 ,3 ]
Busch, Susan H. [4 ]
Busch, Alisa B. [5 ,6 ]
Asch, David A. [1 ,2 ,3 ]
Barry, Colleen L. [3 ,7 ]
机构
[1] Univ Penn, Dept Vet Affairs, Ctr Hlth Equ Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Div Gen Internal Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
[4] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Adm, New Haven, CT USA
[5] McLean Hosp, Belmont, MA 02178 USA
[6] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[7] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
关键词
drug utilization; pharmaceutical policy; physician practice patterns; psychiatry; PHARMACEUTICAL REPRESENTATIVES; PHYSICIANS; INDUSTRY; ATTITUDES; INFORMATION; BEHAVIOR; DRUGS;
D O I
10.1097/MLR.0b013e318277eb19
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Academic medical institutions have instituted conflict of interest (COI) policies in response to concerns about pharmaceutical industry influence. Objective: To determine whether exposure to COI policies during psychiatry residency training affects psychiatrists' antidepressant prescribing patterns after graduation. Research Design: We used 2009 physician-level national administrative prescribing data from IMS Health for 1652 psychiatrists from 162 residency programs. We used difference-in-differences estimation to compare antidepressant prescribing based on graduation before (2001) or after (2008) COI policy adoption across residency program groups with maximally, moderately, and minimally restrictive COI policies. The primary outcomes were shares of psychiatrists' prescribing of heavily promoted, brand reformulated, and brand antidepressants. Results: Rates of prescribing heavily promoted, brand reformulated, and brand antidepressants in 2009 were lower among post-COI graduates than pre-COI graduates at all levels of COI restrictiveness. However, differences between pre-COI and post-COI graduates' prescribing of heavily promoted medications were larger for maximally restrictive programs than both minimally restrictive programs [- 4.3 percentage points; 95% confidence interval (CI), - 7.0, - 1.6] and moderately restrictive programs (- 3.6 percentage points; 95% CI, - 6.2, - 1.1). The difference in prescribing reformulations was larger for maximally restrictive programs than minimally restrictive programs (- 3.0 percentage points; 95% CI, - 5.3, - 0.7). Results were consistent for prescribing of brand drugs. Conclusions: This study provides the first empirical evidence of the effects of COI policies. Our results suggest that COI policies can help inoculate physicians against persuasive aspects of pharmaceutical promotion. Further research should assess whether these policies affect other drug classes and physician specialties similarly.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 32 条
  • [1] Do drug samples influence resident prescribing behavior? A randomized trial
    Adair, RF
    Holmgren, LR
    [J]. AMERICAN JOURNAL OF MEDICINE, 2005, 118 (08) : 881 - 884
  • [2] Angell M., 2004, TRUTH DRUG CO THEY D, V1st ed.
  • [3] [Anonymous], PHRMA COD INT HEALTH
  • [4] [Anonymous], 2008, NY TIMES
  • [5] [Anonymous], 2011, CEG STRAT DAT US PHA
  • [6] Association of American Medical Colleges, 2008, IND FUND MED ED REP
  • [7] BOWER AD, 1987, J FAM PRACTICE, V24, P612
  • [8] Health industry practices that create conflicts of interest - A policy proposal for academic medical centers
    Brennan, TA
    Rothman, DJ
    Blank, L
    Blumenthal, D
    Chimonas, SC
    Cohen, JJ
    Goldman, J
    Kassirer, JP
    Kimball, H
    Naughton, J
    Smelser, N
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (04): : 429 - 433
  • [9] A national survey of physician-industry relationships
    Campbell, Eric G.
    Gruen, Russell L.
    Mountford, James
    Miller, Lawrence G.
    Cleary, Paul D.
    Blumenthal, David
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (17) : 1742 - 1750
  • [10] Physicians, pharmaceutical sales representatives, and the cost of prescribing
    Caudill, TS
    Johnson, MS
    Rich, EC
    McKinney, WP
    [J]. ARCHIVES OF FAMILY MEDICINE, 1996, 5 (04) : 201 - 206